. The company’s pipeline involves 4 medical-stage therapies. Its most Sophisticated drug prospect is ROS1 inhibitor taletrectinib for managing lung cancer. Nuvation is completing two section 2 pivotal reports on taletrectinib. On April eleven, following publishing many tweets crucial in the company, Musk announced he had made a decision https://financefeeds.com/euraud-technical-analysis-report-28-march-2025/